O	0	10	Prognostic	Prognostic	JJ	B-NP
O	11	16	value	value	NN	I-NP
O	17	19	of	of	IN	B-PP
O	20	23	p53	p53	NN	B-NP
O	24	31	protein	protein	NN	I-NP
O	32	42	expression	expression	NN	I-NP
O	43	46	and	and	CC	O
O	47	55	vascular	vascular	JJ	B-NP
O	56	67	endothelial	endothelial	JJ	I-NP
O	68	74	growth	growth	NN	I-NP
O	75	81	factor	factor	NN	I-NP
O	82	92	expression	expression	NN	I-NP
O	93	95	in	in	IN	B-PP
O	96	104	resected	resecte	VBN	B-NP
B-Cancer	105	113	squamous	squamous	JJ	I-NP
I-Cancer	114	118	cell	cell	NN	I-NP
I-Cancer	119	128	carcinoma	carcinoma	NN	I-NP
O	129	131	of	of	IN	B-PP
O	132	135	the	the	DT	B-NP
B-Organ	136	145	esophagus	esophagus	NN	I-NP
O	145	146	.	.	.	O

O	147	150	The	The	DT	B-NP
O	151	155	most	most	RBS	I-NP
O	156	162	common	common	JJ	I-NP
O	163	170	genetic	genetic	JJ	I-NP
O	171	182	alterations	alteration	NNS	I-NP
O	183	188	found	find	VBN	B-VP
O	189	191	in	in	IN	B-PP
O	192	193	a	a	DT	B-NP
O	194	198	wide	wide	JJ	I-NP
O	199	206	variety	variety	NN	I-NP
O	207	209	of	of	IN	B-PP
B-Cancer	210	217	cancers	cancer	NNS	B-NP
O	218	221	are	be	VBP	B-VP
O	222	225	p53	p53	NN	B-NP
B-Cancer	226	231	tumor	tumor	NN	I-NP
O	232	242	suppressor	suppressor	NN	I-NP
O	243	247	gene	gene	NN	I-NP
O	248	257	mutations	mutation	NNS	I-NP
O	257	258	.	.	.	O

O	259	262	p53	p53	NN	B-NP
O	263	270	appears	appear	VBZ	B-VP
O	271	273	to	to	TO	I-VP
O	274	276	be	be	VB	I-VP
O	277	278	a	a	DT	B-NP
B-Cellular_component	279	286	nuclear	nuclear	JJ	I-NP
O	287	300	transcription	transcription	NN	I-NP
O	301	307	factor	factor	NN	I-NP
O	308	312	that	that	WDT	B-NP
O	313	318	plays	play	VBZ	B-VP
O	319	320	a	a	DT	B-NP
O	321	325	role	role	NN	I-NP
O	326	328	in	in	IN	B-PP
O	329	332	the	the	DT	B-NP
O	333	340	control	control	NN	I-NP
O	341	343	of	of	IN	B-PP
B-Cell	344	348	cell	cell	NN	B-NP
O	349	362	proliferation	proliferation	NN	I-NP
O	362	363	,	,	,	O
O	364	373	apoptosis	apoptosis	NN	B-NP
O	373	374	,	,	,	O
O	375	378	and	and	CC	O
O	379	382	the	the	DT	B-NP
O	383	394	maintenance	maintenance	NN	I-NP
O	395	397	of	of	IN	B-PP
O	398	405	genetic	genetic	JJ	B-NP
O	406	415	stability	stability	NN	I-NP
O	415	416	.	.	.	O

O	417	429	Angiogenesis	Angiogenesis	NN	B-NP
O	430	432	is	be	VBZ	B-VP
O	433	434	a	a	DT	B-NP
O	435	443	critical	critical	JJ	I-NP
O	444	451	process	process	NN	I-NP
O	452	454	in	in	IN	B-PP
B-Cancer	455	460	solid	solid	JJ	B-NP
I-Cancer	461	466	tumor	tumor	NN	I-NP
O	467	473	growth	growth	NN	I-NP
O	474	477	and	and	CC	I-NP
O	478	488	metastasis	metastasis	NN	I-NP
O	488	489	.	.	.	O

O	490	498	Vascular	Vascular	JJ	B-NP
O	499	510	endothelial	endothelial	JJ	I-NP
O	511	517	growth	growth	NN	I-NP
O	518	524	factor	factor	NN	I-NP
O	525	526	(	(	(	O
O	526	530	VEGF	VEGF	NN	B-NP
O	530	531	)	)	)	O
O	531	532	,	,	,	O
O	533	534	a	a	DT	B-NP
O	535	543	recently	recently	RB	I-NP
O	544	554	identified	identify	VBN	I-NP
O	555	561	growth	growth	NN	I-NP
O	562	568	factor	factor	NN	I-NP
O	569	573	with	with	IN	B-PP
O	574	585	significant	significant	JJ	B-NP
O	586	596	angiogenic	angiogenic	JJ	I-NP
O	597	607	properties	property	NNS	I-NP
O	607	608	,	,	,	O
O	609	612	may	may	MD	B-VP
O	613	615	be	be	VB	I-VP
O	616	617	a	a	DT	B-NP
O	618	623	major	major	JJ	I-NP
B-Cancer	624	629	tumor	tumor	NN	I-NP
O	630	642	angiogenesis	angiogenesis	NN	I-NP
O	643	652	regulator	regulator	NN	I-NP
O	652	653	.	.	.	O

O	654	657	Few	Few	JJ	B-NP
O	658	665	studies	study	NNS	I-NP
O	666	670	have	have	VBP	B-VP
O	671	683	investigated	investigate	VBN	I-VP
O	684	687	the	the	DT	B-NP
O	688	699	association	association	NN	I-NP
O	700	707	between	between	IN	B-PP
O	708	711	p53	p53	NN	B-NP
O	712	715	and	and	CC	I-NP
O	716	720	VEGF	VEGF	NN	I-NP
O	721	732	expressions	expression	NNS	I-NP
O	733	736	and	and	CC	O
O	737	746	prognosis	prognosis	NN	B-NP
O	747	749	in	in	IN	B-PP
B-Cancer	750	760	esophageal	esophageal	JJ	B-NP
I-Cancer	761	770	carcinoma	carcinoma	NN	I-NP
O	770	771	.	.	.	O

O	772	777	Forty	Forty	CD	B-NP
O	777	778	-	-	HYPH	I-NP
O	778	783	seven	seven	CD	I-NP
B-Multi-tissue_structure	784	793	specimens	specimen	NNS	I-NP
O	794	802	resected	resecte	VBN	B-VP
O	803	807	from	from	IN	B-PP
O	808	816	patients	patient	NNS	B-NP
O	817	821	with	with	IN	B-PP
O	822	827	stage	stage	NN	B-NP
O	828	830	II	II	CD	I-NP
O	831	834	and	and	CC	I-NP
O	835	838	III	III	CD	I-NP
B-Cancer	839	847	squamous	squamous	JJ	I-NP
I-Cancer	848	852	cell	cell	NN	I-NP
I-Cancer	853	862	carcinoma	carcinoma	NN	I-NP
O	863	864	(	(	(	O
B-Cancer	864	867	SCC	SCC	NN	B-NP
O	867	868	)	)	)	O
O	869	871	of	of	IN	B-PP
O	872	875	the	the	DT	B-NP
B-Organ	876	885	esophagus	esophagus	NN	I-NP
O	886	890	were	be	VBD	B-VP
O	891	898	studied	study	VBN	I-VP
O	899	904	using	use	VBG	B-VP
O	905	924	immunohistochemical	immunohistochemical	JJ	B-NP
O	925	933	staining	staining	NN	I-NP
O	933	934	.	.	.	O

O	935	939	VEGF	VEGF	NN	B-NP
O	940	943	and	and	CC	I-NP
O	944	947	p53	p53	NN	I-NP
O	948	959	expressions	expression	NNS	I-NP
O	960	964	were	be	VBD	B-VP
O	965	973	observed	observe	VBN	I-VP
O	974	976	in	in	IN	B-PP
O	977	979	40	40	CD	B-NP
O	979	980	%	%	NN	I-NP
O	981	984	and	and	CC	O
O	985	987	53	53	CD	B-NP
O	987	988	%	%	NN	I-NP
O	989	991	of	of	IN	B-PP
O	992	995	the	the	DT	B-NP
B-Cancer	996	1002	tumors	tumor	NNS	I-NP
O	1002	1003	,	,	,	O
O	1004	1016	respectively	respectively	RB	B-ADVP
O	1016	1017	.	.	.	O

O	1018	1021	The	The	DT	B-NP
O	1022	1025	p53	p53	NN	I-NP
O	1026	1029	and	and	CC	I-NP
O	1030	1034	VEGF	VEGF	NN	I-NP
O	1035	1043	staining	staining	NN	I-NP
O	1044	1052	statuses	status	NNS	I-NP
O	1053	1057	were	be	VBD	B-VP
O	1058	1068	coincident	coincident	JJ	B-ADJP
O	1069	1071	in	in	IN	B-PP
O	1072	1076	only	only	RB	B-NP
O	1077	1079	21	21	CD	I-NP
O	1079	1080	%	%	NN	I-NP
O	1081	1083	of	of	IN	B-PP
O	1084	1087	the	the	DT	B-NP
B-Cancer	1088	1094	tumors	tumor	NNS	I-NP
O	1094	1095	,	,	,	O
O	1096	1099	and	and	CC	O
O	1100	1102	no	no	DT	B-NP
O	1103	1114	significant	significant	JJ	I-NP
O	1115	1126	correlation	correlation	NN	I-NP
O	1127	1130	was	be	VBD	B-VP
O	1131	1136	found	find	VBN	I-VP
O	1137	1144	between	between	IN	B-PP
O	1145	1148	p53	p53	NN	B-NP
O	1149	1152	and	and	CC	I-NP
O	1153	1157	VEGF	VEGF	NN	I-NP
O	1158	1166	statuses	status	NNS	I-NP
O	1166	1167	.	.	.	O

O	1168	1170	No	No	DT	B-NP
O	1171	1188	clinicopathologic	clinicopathologic	JJ	I-NP
O	1189	1196	factors	factor	NNS	I-NP
O	1197	1201	were	be	VBD	B-VP
O	1202	1215	significantly	significantly	RB	I-VP
O	1216	1226	correlated	correlate	VBN	I-VP
O	1227	1231	with	with	IN	B-PP
O	1232	1235	p53	p53	NN	B-NP
O	1236	1238	or	or	CC	I-NP
O	1239	1243	VEGF	VEGF	NN	I-NP
O	1244	1254	expression	expression	NN	I-NP
O	1254	1255	.	.	.	O

O	1256	1258	No	No	DT	B-NP
O	1259	1270	significant	significant	JJ	I-NP
O	1271	1282	association	association	NN	I-NP
O	1283	1290	between	between	IN	B-PP
O	1291	1294	p53	p53	NN	B-NP
O	1295	1298	and	and	CC	I-NP
O	1299	1303	VEGF	VEGF	NN	I-NP
O	1304	1315	expressions	expression	NNS	I-NP
O	1316	1319	and	and	CC	O
O	1320	1324	poor	poor	JJ	B-NP
O	1325	1334	prognosis	prognosis	NN	I-NP
O	1335	1338	was	be	VBD	B-VP
O	1339	1344	found	find	VBN	I-VP
O	1344	1345	.	.	.	O

O	1346	1348	In	In	IN	B-PP
O	1349	1359	conclusion	conclusion	NN	B-NP
O	1359	1360	,	,	,	O
O	1361	1364	p53	p53	NN	B-NP
O	1365	1368	and	and	CC	I-NP
O	1369	1373	VEGF	VEGF	NN	I-NP
O	1374	1378	were	be	VBD	B-VP
O	1379	1382	not	not	RB	I-VP
O	1383	1393	correlated	correlate	VBN	I-VP
O	1394	1398	with	with	IN	B-PP
O	1399	1408	prognosis	prognosis	NN	B-NP
O	1409	1411	in	in	IN	B-PP
O	1412	1420	patients	patient	NNS	B-NP
O	1421	1425	with	with	IN	B-PP
O	1426	1431	stage	stage	NN	B-NP
O	1432	1434	II	II	CD	I-NP
O	1435	1438	and	and	CC	I-NP
O	1439	1442	III	III	CD	I-NP
B-Cancer	1443	1446	SCC	SCC	NN	I-NP
O	1447	1449	of	of	IN	B-PP
O	1450	1453	the	the	DT	B-NP
B-Organ	1454	1463	esophagus	esophagus	NN	I-NP
O	1463	1464	.	.	.	O

